ATE229328T1 - Venlafaxin und seine analoga zum herbeiführen einer verbesserung der kognitiven funktionen - Google Patents

Venlafaxin und seine analoga zum herbeiführen einer verbesserung der kognitiven funktionen

Info

Publication number: ATE229328T1
Authority: AT; Austria
Prior art keywords: alkyl; hydrogen; venlafaxine; analogues; cognitive functions
Prior art date: 1994-02-14

Application number

AT95300612T

Other languages

English (en)

Inventor

George Edward Morris Husbands

Magid Abdel-Megid Abou-Gharbia

John Allen Moyer

Eric Anthony Muth

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-14

Filing date

1995-01-31

Publication date

2002-12-15

1995-01-31 Application filed by Wyeth Corp filed Critical Wyeth Corp

2002-12-15 Application granted granted Critical

2002-12-15 Publication of ATE229328T1 publication Critical patent/ATE229328T1/de

Links

230000003920 cognitive function Effects 0.000 title 1
PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title 1
229960004688 venlafaxine Drugs 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 5
229910052739 hydrogen Inorganic materials 0.000 abstract 4
239000001257 hydrogen Substances 0.000 abstract 4
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
150000001875 compounds Chemical class 0.000 abstract 2
-1 or taken together Chemical group 0.000 abstract 2
125000004423 acyloxy group Chemical group 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000003282 alkyl amino group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
125000001589 carboacyl group Chemical group 0.000 abstract 1
230000019771 cognition Effects 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Psychiatry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Carbon And Carbon Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Traffic Control Systems (AREA)
Medicines Containing Plant Substances (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT95300612T 1994-02-14 1995-01-31 Venlafaxin und seine analoga zum herbeiführen einer verbesserung der kognitiven funktionen ATE229328T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US19541794A	1994-02-14	1994-02-14

Publications (1)

Publication Number	Publication Date
ATE229328T1 true ATE229328T1 (de)	2002-12-15

Family

ID=22721346

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95300612T ATE229328T1 (de)	1994-02-14	1995-01-31	Venlafaxin und seine analoga zum herbeiführen einer verbesserung der kognitiven funktionen

Country Status (11)

Country	Link
EP (2)	EP1245228A3 (de)
JP (1)	JPH07252143A (de)
AT (1)	ATE229328T1 (de)
CA (1)	CA2141774A1 (de)
CY (1)	CY2321B1 (de)
DE (1)	DE69529109T2 (de)
DK (1)	DK0667150T3 (de)
ES (1)	ES2185683T3 (de)
LV (1)	LV13000B (de)
PT (1)	PT667150E (de)
SG (1)	SG49680A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6274171B1 (en)	1996-03-25	2001-08-14	American Home Products Corporation	Extended release formulation of venlafaxine hydrochloride
US6342533B1 (en) *	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) *	1999-04-06	2003-02-10	Sepracor Inc	Derivatives of venlafaxine and methods of preparing and using the same
AU2002250058B2 (en) *	2001-02-12	2007-08-16	Wyeth Llc	Novel succinate salt of O-desmethyl-venlafaxine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4535186A (en) *	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
DE69429895T2 (de) *	1993-06-28	2002-08-29	American Home Products Corp., Madison	Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten

1995
- 1995-01-31 EP EP02014620A patent/EP1245228A3/de not_active Withdrawn
- 1995-01-31 AT AT95300612T patent/ATE229328T1/de not_active IP Right Cessation
- 1995-01-31 DK DK95300612T patent/DK0667150T3/da active
- 1995-01-31 SG SG1996004003A patent/SG49680A1/en unknown
- 1995-01-31 DE DE69529109T patent/DE69529109T2/de not_active Expired - Fee Related
- 1995-01-31 ES ES95300612T patent/ES2185683T3/es not_active Expired - Lifetime
- 1995-01-31 EP EP95300612A patent/EP0667150B1/de not_active Expired - Lifetime
- 1995-01-31 PT PT95300612T patent/PT667150E/pt unknown
- 1995-02-03 CA CA002141774A patent/CA2141774A1/en not_active Abandoned
- 1995-02-13 JP JP7023837A patent/JPH07252143A/ja not_active Withdrawn
2003
- 2003-03-17 LV LVP-03-34A patent/LV13000B/en unknown
- 2003-03-24 CY CY0300031A patent/CY2321B1/xx unknown

Also Published As

Publication number	Publication date
LV13000B (en)	2003-07-20
CA2141774A1 (en)	1995-08-15
EP1245228A2 (de)	2002-10-02
SG49680A1 (en)	1998-06-15
DK0667150T3 (da)	2003-03-31
EP1245228A3 (de)	2002-10-09
ES2185683T3 (es)	2003-05-01
EP0667150A1 (de)	1995-08-16
CY2321B1 (en)	2003-11-14
EP0667150B1 (de)	2002-12-11
DE69529109D1 (de)	2003-01-23
JPH07252143A (ja)	1995-10-03
PT667150E (pt)	2003-02-28
DE69529109T2 (de)	2003-04-30

Legal Events

Date

Code

Title

Description

2003-06-15

UEP

Publication of translation of european patent specification

Ref document number: 0667150

Country of ref document: EP

2010-10-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69133455D1 (de)	2005-06-02	Zwischenprodukte zur Herstellung von Camptothecin und Analogen
DE69334250D1 (de)	2009-01-29	Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
PT1738753E (pt)	2008-06-19	Novos tratamentos utilizando derivados de fenetilamina
ES2061670T3 (es)	1994-12-16	Cicloalcanoles substituidos.
DE3683483D1 (de)	1992-02-27	Neue benzothiazinabkoemmlinge.
SG165991A1 (en)	2010-11-29	Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives
PE20040175A1 (es)	2004-03-29	Metodo para tratar enfermedades o condiciones desmielinizantes
ATE229328T1 (de)	2002-12-15	Venlafaxin und seine analoga zum herbeiführen einer verbesserung der kognitiven funktionen
EG16546A (en)	1990-10-30	Therapeutic agents
DK526087A (da)	1988-04-08	Antikonvulsive aminosyrederivater
DE3375784D1 (en)	1988-04-07	1,3,4,6,7,11b-hexahydro-7-aryl-2h-pyrazino (2,1-alpha) isoquinolines useful as intermediates and pharmaceutical compounds and methods of preparation
ATE52776T1 (de)	1990-06-15	1-phenyl-3-benzazepine.
TW275629B (de)	1996-05-11
LU88449I2 (fr)	1994-09-09	Fleroxacine et ses dérivés pharmaceutiquement acceptables.
ES512430A0 (es)	1983-06-01	"un procedimiento para preparar derivados de dimetil-propanamida".
JO1621B1 (en)	1991-11-27	Therapeutic agents